Setlai BP, Hull R, Bida M, Durandt C, Mulaudzi TV, Chatziioannou A, et al. Immunosuppressive Signaling Pathways as Targeted Cancer Therapies. Biomedicines. 2022;10(3).
Immunosuppressive Signaling Pathways as Targeted Cancer Therapies.
By Content Specialist|2022-06-20T09:48:39+02:00June 20, 2022|2022 Publication, 2022: January to March|Comments Off on Immunosuppressive Signaling Pathways as Targeted Cancer Therapies.
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Recency of HIV infection, antiretroviral therapy use and viral loads among symptomatic sexually transmitted infection service attendees in South Africa